Our mission is to improve the quality of life for BIPOC who are affected by IBD, Digestive Disorders and associated Chronic Illnesses; through Community, Research, Education, and Advocacy.

A Real Picture Of Health:
Dominique Daniels
2024

A Real Picture of Health

“Having access to Advance Therapeutics is important because patients all suffer from different types of illnesses and having the option to choose what is right for us is important.”

 

Dominique was initially hesitant about trying an Advanced Therapeutic drug, but once she started, her life changed.

 

Being symptom free gave her more freedom to manage her everyday life with less worries. something all patients want to experience.

 

While she has currently achieved remission, her journey with medication was long and often involved lots of back and forth with her insurance company to approve medications. To this day, there is still an issue sometimes with approving the medication that works best for her treatment.

 

Ultimately, her messaging is, “All patients deserve the medication they need to live a healthy life!”

Advanced Therapies

Evidence has shown that TNF inhibitors may be less effective in certain populations, particularly Black patients with IBD. A study published in Oxford Academic highlighted that Black IBD patients on anti-TNF therapy experienced higher rates of active disease and hospitalizations compared to their White counterparts. This underscores the urgent need to eliminate barriers to advanced therapeutic options like JAK inhibitors, which offer unique benefits, including oral administration, improved efficacy for certain patient populations, and reduced delays in achieving adequate disease management.

At COGI, we recognize the profound physical, mental, and financial toll of digestive diseases on patients and their families. Restrictive policies that hinder access to innovative treatments exacerbate these burdens, particularly for historically marginalized communities that already face healthcare inequities.

Patients living with chronic illnesses deserve timely access to therapies that best meet their individual needs. Decisions about the risks and benefits of treatments should remain within the physician-patient partnership, informed by the patient’s unique health circumstances.

Innovation in treatment is essential to improving quality of life for patients with digestive diseases.

Advanced Therapy Stories <br> Sponsored by:

Advanced Therapy Stories
Sponsored by:

Image

Join Our Community

Find us on the following platforms and join the conversation!

SIGN UP FOR OUR NEWSLETTER

Subscribe to our newsletter!

Never miss an update. Receive periodic emails from us, and cancel at any time.

This field is for validation purposes and should be left unchanged.